No Data
No Data
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex Pharmaceuticals (NASDAQ:VRTX) revealed 16 unusual trades.Delving into the de
SLB, First Solar And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades.When insiders sell shares, it could be a preplanned sale, or could indicate their concer
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
Joseph M. Terranova of Virtus Investment Partners named VanEck Semiconductor ETF (NASDAQ:SMH) on CNBC's "Halftime Report Final Trades." If NVIDIA Corporation (NASDAQ:NVDA) goes above the $1,000 level,
6 Analysts Have This To Say About Encompass Health
6 analysts have expressed a variety of opinions on Encompass Health (NYSE:EHC) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view
Encompass Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 10.77% RBC Capital $83 → $95 Maintains Outperform 04/26/2024 10.77% Raymond James $85 → $95 Rei
Resonac, Kakaku.com, etc. (added) Rating
Downgrading-Bearish Code | Stock Name | Securities Company | Conventional | After Change |------|-----------------|----------|--------|--------|<4041>|Nisso | Daiwa | “2” | “3” |Target Stock Price Change Code | Stock Name | Securities Company | Traditional | After Change |------|-----------------|--------